 SEATTLE and VANCOUVER, British Columbia, Feb. 02, 2022 GLOBE NEWSWIRE -- Achieve Life Sciences, Inc. NASDAQ: ACHV, a clinical-stage pharmaceutical company committed to the global development and commercialization of cytisinicline for smoking cessation and nicotine addiction, today announced it will be participating in the Winter Wonderland Best Ideas Virtual Investor Conference and Aegis Virtual Conference during February 2022. 